Vitamin C–functionalized copper nanozymes for treating drug-resistant intracellular infections and hyperinflammation

(MRSA)-induced peritonitis mouse model, CVs achieved robust intracellular bacterial clearance and inflammation resolution, underscoring their potential as next-generation copper-based nanomaterials for treating refractory intracellular bacterial infections and hyperinflammation-related disorders.